baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

CELGENE ORD SHS/ US1510201049 /

20/11/2019 00:00:00	Chg. -	Volume	Bid-	Ask-	High	Low
107.94USD	-	826,453 Turnover: -	-Bid Size: -	-Ask Size: -	108.13	100.05

GlobeNewswire 02/05 PDS Biotech Appoints Stephan Toutain as Chief Operating Officer

GlobeNewswire 01/05 Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

GlobeNewswire 24/04 Oruka Therapeutics Expands Leadership Team, Naming Joana Goncalves, MBChB, as Chief Medical Officer

GlobeNewswire 08/04 TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H.,...

GlobeNewswire 01/04 Autolus Therapeutics Announces Changes to its Board of Directors

GlobeNewswire 12/03 Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual ...

GlobeNewswire 16/02 Smart Immune appoints key new members to its Board of Directors

GlobeNewswire 05/01 ArriVent Appoints Winston Kung as Chief Financial Officer and Treasurer

GlobeNewswire 19/12/2023 Related Sciences Adds 8 New Senior Advisors Including Former CEOs and Heads of R&D from Genentech, N...

GlobeNewswire 11/12/2023 Immodulon Announces Formation of New Scientific Advisory Board to Support Late-stage Clinical Develo...

GlobeNewswire 04/12/2023 TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as ...

GlobeNewswire 04/12/2023 Smart Immune appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer, strengthening C suite with...

GlobeNewswire 14/11/2023 Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis

GlobeNewswire 13/11/2023 Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments

GlobeNewswire 24/10/2023 Onconova Expands Leadership Team with Two Key Appointments

GlobeNewswire 17/10/2023 Cellectar Biosciences Expands Commercialization Leadership Team Ahead of Pivotal Data for Iopofosine...

GlobeNewswire 16/10/2023 CRISPR Therapeutics Proposes New Appointment to the Board of Directors

GlobeNewswire 16/10/2023 Modifi Bio Raises Additional $4.3 Million in Seed Funding

GlobeNewswire 26/09/2023 Candel Therapeutics Reports Encouraging Initial Survival Data from Phase 2 Clinical Trial of CAN-240...

GlobeNewswire 15/09/2023 Repairon Appoints Co-Founder Dr. Lothar Germeroth as Chief Executive Officer

GlobeNewswire 12/09/2023 CARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officer

GlobeNewswire 12/09/2023 Abeona Therapeutics Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial Officer

GlobeNewswire 11/09/2023 SalioGen Therapeutics Appoints Jason F. Cole as Chief Executive Officer and Chairman of the Board of...

GlobeNewswire 05/09/2023 NANOBIOTIX Strengthens Global Development Capabilities With the Appointment of Veteran Industry Lead...

GlobeNewswire 29/08/2023 Faron Reports Half-Year Financial Results, January 1 – June 30, 2023

CELGENE ORD SHS/ US1510201049 /

If you wish to receive reply to your feedback, please provide your email address.